Pharmaceutical manufacturer scaling AI and regulatory compliance infrastructure
Yunnan Baiyao Group is a publicly traded Chinese pharmaceutical manufacturer with ~916 employees, actively building large language model capabilities and AI platform architecture alongside radiopharmaceutical development. The tech stack—Java, Python, PyTorch, TensorFlow, with Oracle and MySQL at the data layer—reflects a hybrid approach: enterprise legacy systems supporting core manufacturing and supply chain, paired with emerging ML/AI infrastructure. Hiring mix skews toward mid-career engineering (10 roles) and research (10 roles), with notable gaps in sales leadership, signaling internal product-development focus over market expansion.
Notable leadership hires: Medical Director, E-commerce Director, Medical Aesthetic Director
Yunnan Baiyao Group manufactures pharmaceuticals from its headquarters in Kunming, Yunnan Province, China. The company operates across traditional pharmaceutical production (lyophilized powders, injections), radiopharmaceutical development, and emerging e-commerce channels. Current project portfolio spans regulatory infrastructure (legal and compliance management systems), clinical quality assurance (adverse event reporting, study design), and strategic diversification into AI-powered platforms and customer service automation. Pain points cluster around medical risk management, contract and tax compliance, and cross-functional coordination—typical for regulated manufacturers scaling into new therapeutic areas and digital channels.
PyTorch and TensorFlow form the ML backbone; TensorRT and CUDA enable GPU acceleration. Python and Java support model development and production serving via Spring Boot microservices.
Large language model capabilities, AI platform architecture, radiopharmaceutical process development, legal compliance systems, and full customer service automation.
Other companies in the same industry, closest in size